Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL10955029 | 1.00 | CA1 (0.80) | — | |
| Acetic Acid SCHEMBL1986019 | 1.00 | CA1 (0.80) | — | |
| Acetic Acid SCHEMBL10956871 | 0.95 | CA1 (0.73) | — | |
| Acetic Acid SCHEMBL1987748 | 0.95 | CA1 (0.82) | — | |
| Acetic Acid SCHEMBL18529905 | 0.95 | CA1 (0.73) | — | |
| Acetic Acid SCHEMBL10777299 | 0.95 | CA1 (0.73) | — | |
| Acetic Acid SCHEMBL449428 | 0.95 | CA1 (0.82) | — | |
| Acetic Acid SCHEMBL2407889 | 0.95 | CA1 (0.89) | — | |
| Acetic Acid SCHEMBL23872 | 0.95 | — | — | |
| Acetic Acid SCHEMBL586756 | 0.95 | CA1 (0.89) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3099760-A1 | HALOGEN-FREE SOLID FLAME RETARDANT MIXTURE AND USE THEREOF | Clariant International Ltd (CH) | 2016-12-07 | — | — | EP | claimed |
| US-20160340588-A1 | Halogen-Free Solid Flame Retardant Mixture And Use Thereof | CLARIANT INTERNATIONAL LTD. (CH) | 2016-11-24 | — | — | US | claimed |
| WO-2015113740-A1 | HALOGEN-FREE SOLID FLAME RETARDANT MIXTURE AND USE THEREOF | CLARIANT INTERNATIONAL LTD (CH) | 2015-08-06 | — | — | WO | claimed |
| US-4673519-A | Low-energy process for the manufacture of calcium/magnesium acetate-chloride deicers and freezing point depressants | GANCY ALAN B | 1987-06-16 | — | — | US | claimed |
| US-4511485-A | Nonpolluting salts and method of making same | GANCY ALAN B | 1985-04-16 | — | — | US | claimed |
| CN-111718688-B | Environment-friendly snow-melting agent and production method thereof | 宁波环洋新材料股份有限公司 | 2021-04-09 | — | — | CN | disclosed |
| CN-111718688-A | Environment-friendly snow-melting agent and production method thereof | 宁波环洋新材料股份有限公司 | 2020-09-29 | — | — | CN | disclosed |
| EP-3099760-A1 | HALOGEN-FREE SOLID FLAME RETARDANT MIXTURE AND USE THEREOF | Clariant International Ltd (CH) | 2016-12-07 | — | — | EP | disclosed |
| US-20160340588-A1 | Halogen-Free Solid Flame Retardant Mixture And Use Thereof | CLARIANT INTERNATIONAL LTD. (CH) | 2016-11-24 | — | — | US | disclosed |
| WO-2015113740-A1 | HALOGEN-FREE SOLID FLAME RETARDANT MIXTURE AND USE THEREOF | CLARIANT INTERNATIONAL LTD (CH) | 2015-08-06 | — | — | WO | disclosed |
| CN-101735634-A | Microgel latex with modified hydroxyl group and a property of stable storage | LANXESS DEUTSCHLAND GMBH | 2010-06-16 | — | — | CN | disclosed |
| US-20050197501-A1 | Processes for preparing calcium salt forms of statins | TEVA PHARMACEUTICAL INDUSTRIES LTD. | 2005-09-08 | — | — | US | disclosed |
| US-20040176615-A1 | Processes for preparing calcium salt forms of statins | NIDDAM-HILDESHEIM VALERIE (IL) | 2004-09-09 | — | — | US | disclosed |
| US-6777552-B2 | FROM AN ESTER DERIVATIVE OR PROTECTED ESTER DERIVATIVE OF THE STATIN BY USING CALCIUM HYDROXIDE | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 2004-08-17 | — | — | US | disclosed |
| EP-1425287-A1 | PROCESSES FOR PREPARING CALCIUM SALT FORMS OF STATINS | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2004-06-09 | — | — | EP | disclosed |
| US-20030114685-A1 | Processes for preparing calcium salt forms of statins | TEVA PHARMACEUTICAL INDUSTRIES, LTD. (IL) | 2003-06-19 | — | — | US | disclosed |
| WO-2003016317-A1 | PROCESSES FOR PREPARING CALCIUM SALT FORMS OF STATINS | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2003-02-27 | — | — | WO | disclosed |
| CN-1353194-A | Process for preparing 20% dextral glycoanhydride iron | YANG MIN (CN) | 2002-06-12 | — | — | CN | disclosed |
| US-4673519-A | Low-energy process for the manufacture of calcium/magnesium acetate-chloride deicers and freezing point depressants | GANCY ALAN B | 1987-06-16 | — | — | US | disclosed |
| US-4511485-A | Nonpolluting salts and method of making same | GANCY ALAN B | 1985-04-16 | — | — | US | disclosed |